Perfluorooctanoic acid (PFOA) has emerged as a significant concern for public health and environmental safety because of its persistence in the environment and its accumulation in the human body. With an enforceable federal drinking water limit now in place, demand for effective PFOA treatment has grown sharply. This article covers the technologies that remove PFOA, how they compare, the regulatory requirements that drive treatment, and the practical factors that determine performance and cost.
PFOA is one of several PFAS compounds with its own treatment behavior, compared in our overview of PFAS removal by compound.
PFOA is an eight-carbon perfluorinated carboxylic acid historically used in manufacturing fluoropolymers for non-stick coatings, and associated with firefighting foams and stain-resistant fabrics. Major U.S. manufacturers phased out PFOA by the mid-2010s, replacing it with alternatives such as the GenX chemicals discussed in our guide to GenX removal from water. Its persistence means contamination from past use and release remains widespread.
PFOA exposure has been linked to developmental effects, immune suppression, elevated cholesterol, and certain cancers. The International Agency for Research on Cancer classifies PFOA as carcinogenic to humans. According to the Agency for Toxic Substances and Disease Registry, PFOA remains in the human body for years, which is why chronic exposure through drinking water is the central concern.
EPA’s drinking water regulation, finalized in April 2024, sets two values for PFOA that are often confused:
A figure of 0.004 parts per trillion sometimes appears in discussions of PFOA. That was EPA’s interim health advisory from 2022, which was not enforceable and was below the level laboratories could measure. The enforceable limit is 4.0 ppt — one thousand times higher.
Compliance with the MCL was originally required by 2029. In May 2026, EPA proposed retaining the PFOA and PFOS limits while allowing systems to request an extension to 2031. As of September 2026, the proposal has not been finalized. PFOA is regulated alongside PFOS, and treatment is almost always planned for the two together — see our coverage of PFOS removal technology.
PFOA in drinking water is measured by liquid chromatography with tandem mass spectrometry (LC-MS/MS) using EPA Method 533 or Method 537.1, the two methods approved for compliance monitoring. Gas chromatography is not used for PFOA compliance analysis. Because the regulatory limit is measured in parts per trillion, samples must be collected with PFAS-free materials and field blanks to avoid contamination.
One of the most widely known cases of PFOA contamination occurred in Hoosick Falls, New York, where PFOA from local manufacturing was found in the village water supply in the mid-2010s. The response included granular activated carbon treatment on the municipal system and point-of-entry filters for private wells. The case became a significant driver of state and national attention to PFAS in drinking water.
EPA identifies granular activated carbon, anion exchange, and high-pressure membranes as effective PFAS treatment technologies. All three remove PFOA from water without destroying it.
GAC is the most widely installed technology for PFOA removal. It adsorbs PFOA effectively and can reduce concentrations below detection when the bed is fresh. PFOA adsorbs less strongly than PFOS — the carboxylate head group binds less tightly than a sulfonate — so PFOA breaks through a GAC bed earlier. Media life depends heavily on empty bed contact time, carbon type, and competition from natural organic matter.
PAC is dosed directly into water and removed with settled solids. It is used mainly as a short-term or interim measure, because the doses needed to meet parts-per-trillion limits make it expensive for continuous use, and the carbon is not reused.
PFAS-selective anion exchange resins remove PFOA efficiently and typically achieve longer run times than GAC at shorter contact times, allowing smaller vessels. Resins are generally used once rather than regenerated, and replacement and disposal are the main operating costs.
High-pressure membranes reject PFOA at very high rates, commonly exceeding 99 percent for reverse osmosis. Higher capital and energy costs, water loss to the reject stream, and management of the PFAS-containing concentrate have limited municipal adoption compared with adsorptive media. At the household scale, point-of-use RO systems are an effective PFOA option, and choosing one is covered in our guide to finding a water filter that removes PFOA.
Conventional advanced oxidation processes — ozone, UV/peroxide, and similar hydroxyl radical systems — do not effectively degrade PFOA. The perfluorinated chain resists hydroxyl radical attack, and these processes can convert some precursors into PFOA. They should not be included in PFOA treatment designs. Destruction technologies capable of breaking down PFOA, such as electrochemical oxidation and plasma treatment, are being developed for concentrated waste streams rather than for treating drinking water directly.
Spent GAC, spent resin, and membrane concentrate all contain the PFOA removed from water. Disposal and reactivation options are narrowing as landfill and incineration practices come under scrutiny, and residuals management should be evaluated from the start of design.
Treatment cost is driven largely by media replacement frequency, which depends on source water characteristics. Pilot testing on actual source water is the most reliable basis for estimating long-term cost, and federal and state funding programs for emerging contaminants can offset capital expenditure.
Compliance is determined against the enforceable 4.0 ppt MCL based on running annual averages of monitoring results, not against the MCLG. Systems should confirm monitoring frequency and reporting requirements with their state primacy agency, which implements the federal rule.
Clear communication of monitoring results and treatment plans builds public trust, particularly while compliance timelines are being revised and residents encounter conflicting information about PFAS limits.
Development is focused on more selective adsorbents, regenerable media, and destruction technologies that can treat the concentrated residuals produced by separation processes. Biological treatment processes such as membrane bioreactors do not remove PFOA and are not part of this development path.
Source control — restricting PFAS use and discharges — reduces the treatment burden on water systems over time. Funding from federal infrastructure programs and settlements with PFAS manufacturers is helping utilities finance treatment.
PFOA treatment rests on three proven technologies — granular activated carbon, anion exchange, and high-pressure membranes — each with its own balance of cost, performance, and residuals burden. The enforceable limit is 4.0 parts per trillion, with an optional extension to 2031 proposed but not yet final.
Effective treatment begins with characterizing the full PFAS profile, pilot testing on actual source water, and planning for residuals management from the outset. Utilities that complete that groundwork are best positioned to meet the PFOA standard reliably and cost-effectively.